N 6 ‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis

May 15, 2025Cancer communications (London, England)

How m6A-modified RNA controls tiny particle release to create an immune-suppressing environment before stomach cancer spreads to the abdomen

AI simplified

Abstract

Overexpression of METTL3 in gastric cancer cells is associated with enhanced RAB27A translation and increased exosome biogenesis.

  • METTL3 modifies the mRNA of RAB27A, facilitating its translation and promoting exosome production.
  • Exosomes derived from METTL3-overexpressed cells contain the miRNA-17-92 cluster, which targets SRCIN1 to activate SRC signaling in peritoneal macrophages.
  • Activated macrophages produce a shift in cytokine profiles, elevating IL-10 and TNF while reducing IL-1 and IL-6.
  • This cytokine shift is linked to inhibited T cell proliferation and cytotoxic activities, contributing to an immunosuppressive environment.
  • The relationship between METTL3, macrophage activation, and peritoneal metastasis is supported by clinical sample analysis.

AI simplified

Key numbers

5.146
Increased Risk of Peritoneal Metastasis
Odds ratio comparing METTL3-high to METTL3-low gastric cancer patients.
2.4×
Cytokine Elevation
Fold increase in IL-10 levels compared to control exosomes.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free